N1-methylnicotinamide as a possible modulator of cardiovascular risk markers in polycystic ovary syndrome-Reference-Cited by-同舟云学术

N1-methylnicotinamide as a possible modulator of cardiovascular risk markers in polycystic ovary syndrome

Published:2019-10 Issue: Volume:235 Page:116843
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Nejabati Hamid Reza^ORCID,Samadi Nasser^ORCID,Roshangar Leila,Nouri Mohammad^ORCID

Funder

Tabriz University of Medical Sciences

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference113 articles.

1. Polycystic ovary syndrome;Azziz;Nat Rev Dis Primers,2016

2. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment;Escobar-Morreale;Nat Rev Endocrinol,2018

3. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome;Escobar-Morreale;Endocr. Rev.,2005

4. Bajuk Studen K, Pfeifer M. Cardiometabolic risk in polycystic ovary syndrome. Endocr Connect. 2018;7:R238-R51.

5. The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome;Barber;Horm. Mol. Biol. Clin. Invest.,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary exosomal metabolites: Overlooked clue for predicting cardiovascular risk;Clinica Chimica Acta;2023-07

2. N1-Methylnicotinamide: The Mysterious Anti-aging Actor in Renal Transplantation;Current Pharmaceutical Design;2023-03

3. N1-Methylnicotinamide: Is it Time to Consider it as a Dietary Supplement for Athletes?;Current Pharmaceutical Design;2022-03

4. Nutraceutical and Dietary Strategies for Up-Regulating Macroautophagy;International Journal of Molecular Sciences;2022-02-12

5. Chronic Low Grade Inflammation in Pathogenesis of PCOS;International Journal of Molecular Sciences;2021-04-06